“I sometimes forget I’m even wearing a pump.”
Amelie (33) has been living with type 1 diabetes since she was seven. For many years, she used the Accu-Chek […]
Blog page
ViCentra scales manufacturing, triples capacity to 17,000+Users
Commercial-scale production of Kaleido consumables begins at contract manufacturer Phillips Medisize Manufacturing capacity more than triples, with initial capacity to
ViCentra Announces Commercial Launch of New Smartphone-Controlled Kaleido Automated Insulin Delivery Patch Pump System
• New system combines Kaleido with Diabeloop’s DBLG2 algorithm and Dexcom G7, with first commercial deliveries in Germany and the
“So many years with Roche. And now I wouldn’t want to go back.”
Ina Verdoold (60) has lived with diabetes for almost her entire life. For years, she used Roche’s Accu-Chek insulin pump.
From Roche to Kaleido: “Sometimes I don’t even realise I’m wearing it”
For two years, Jan de Groot (58) from Velserbroek relied on Roche’s Accu‑Chek Insight insulin pump. When Roche announced at
“I can hardly feel my pump. Sometimes I even think: is it still there?”
Jannet Storm (61) works three mornings a week as a support assistant in a group of toddlers with physical disabilities.
Kaleido is now immediately available — no waiting period to get started
We’re excited to share an important update: Kaleido is now immediately available, with no waiting period to get started. Kaleido
Update regarding prescriptions of the Kaleido pump with Dexcom G6
Start Today. Ready for What’s Next At ViCentra the company behind Kaleido, we understand that stability and reliability are essential
Paulina Takes on Cotopaxi and Chimborazo with Kaleido by Her Side
From quiet trails in the Alps and iconic trails in the Tatras, all the way to the volcanic landscapes of
ViCentra Appoints Diabetes Commercialization Leader Reman McDonagh as Vice President, Global Marketing
Marketing executive brings 20+ years of global diabetes experience to support European scale-up and next-generation Kaleido launch readiness Utrecht, the